ATA CAPITAL BACKS RCA IN MANAGEMENT BUYOUT

10 November, 2021

JOHANNESBURG (10 November 2021) Ata Capital (Pty) Ltd (“Ata Capital”), a leading private equity (“PE”) investment management firm and Respiratory Care Africa Pty Ltd (“RCA”), a medical devices supplier, are pleased to announce the successful completion of the management buyout (MBO) of RCA from South African healthcare group Ascendis Health (“Ascendis”). The MBO was financed through Ata Capital’s latest BEE value fund, Ata Fund III and makes the PE firm a majority shareholder.

This MBO has enabled RCA to return to its original status as a 100% South African, privately owned medical devices company. The MBO opportunity is a result of Ascendis’ asset divestment and group recapitalisation strategy.

Commenting on the MBO, Ata Capital’s CEO, Mamedupi Matsipa said, “We believe that this investment offers significant growth prospects. As a leading supplier of ventilators and high-flow nasal oxygen equipment to both public and private hospitals, RCA has been instrumental in the fight against COVID-19. RCA has performed exceptionally well during the pandemic, and the increase in its device install base since early 2020 has created the potential for continued enhanced profitability through increased support and consumables sales once the pandemic subsides and trading conditions normalise. We are proud to partner with excellence.”

Established in 1998, RCA is a supplier of respiratory, monitoring, radiology and other medical equipment and consumables used in the treatment of patients at hospitals (with a focus on high care, intensive care units, operating theatres, and maternity wards) and in the home. It also provides its customers with technical support, services, and consumables.

RCA, Managing Director, Christiaan De Wet commented, “We are elated that this transaction lets us once again become a 100% South African, privately owned company. Allowing the business agility  to operate & adapt the business to cope with this everchanging healthcare environment.

Share this article:

RETURN TO ARTICLES
INVEST WITH US
ata-logo-white

INFORMATION ACT

CONNECT WITH US:

Facebook Linkedin

Ata Capital (Pty) Ltd (Registration Number 2006/028451/07) is an authorised Category I and II Financial Services Provider (“FSP”) in terms of the Financial Advisory and Intermediary Services Act, 37 of 2002 (“FAIS Act”) with FSP number 46869.

Made by Lifa Communications.

ata-logo-white

FAIS Act Disclaimer

Ata Capital (Pty) Ltd (Registration Number 2006/028451/07) is an authorised Category I and II Financial Services Provider (“FSP”) in terms of the Financial Advisory and Intermediary Services Act, 37 of 2002 (“FAIS Act”) with FSP number 46869. The information and/or opinions contained herein should not be construed as advice as defined in the FAIS Act; neither do they constitute a solicitation, invitation or investment recommendation. Investors should take cognisance of the fact that there are risks involved when buying, selling or investing in any financial product. The value of investments may fall as well as rise, and investors may not recover the capital invested.

Given that value of investments will fluctuate over time and that past returns may not be indicative of future performance, investors should seek independent professional financial, legal and tax advice relevant to their individual circumstances before making any investment decision. The validity and accuracy of any illustrations, forecasts or hypothetical data are not guaranteed and are provided for illustrative purposes only.

Conflict of Interest

A copy of the latest version of our Conflict of Interest Policy can be obtained by sending an emailed request to info@atacapital.co.za

POPIA Compliance

Ata Capital’s data management policies are aligned with, and comply with, the provisions of the Protection of Personal Information Act, 4 of 2013 (“POPI Act”). A copy of our POPIA Manual can be obtained by sending an emailed request to info@atacapital.co.za

By accessing this website, you are assumed to have read and to have understood the contents of this disclaimer.

AGREE